5-HT1A-receptor over-expressing mice: Genotype and sex dependent responses to antidepressants in the forced swim-test

Neuropharmacology

Volumn 61, Issue 3, 2011, Pages 433-441

  Günther, Lydia ^a   Rothe, Julia ^b   Rex, André ^c   Voigt, Jörg Peter ^d   Millan, Mark J ^e   Fink, Heidrun ^b   Bert, Bettina ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

5 HT1A receptor; Buspirone; Citalopram; Depression; Forced swim; Over expression; Postsynaptic; Reboxetine; S 15535

Indexed keywords

1 (1,4 BENZODIOXAN 5 YL) 4 (2 INDANYL)PIPERAZINE; BUSPIRONE; CITALOPRAM; REBOXETINE; SEROTONIN 1A RECEPTOR; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED SWIMMING TEST; GENOTYPE; LIMBIC CORTEX; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN BINDING; SEROTONINERGIC TRANSMISSION; SEX DIFFERENCE; TRANSGENE; ANTIDEPRESSANT ACTIVITY; AUTORADIOGRAPHY; BRAIN REGION; CONFERENCE PAPER; CORTICOLIMBIC AREA; DRUG EFFECT; DRUG MEGADOSE; DRUG RECEPTOR BINDING; GENE OVEREXPRESSION; IMMOBILIZATION; QUANTITATIVE ANALYSIS; SEX RATIO; TREATMENT RESPONSE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CITALOPRAM; DEPRESSION; FEMALE; LIMBIC SYSTEM; MALE; MICE; MICE, TRANSGENIC; MORPHOLINES; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEURONS; ORGAN SPECIFICITY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS;

EID: 79958106058     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.03.004     Document Type: Article

References (64)

1. A. Adell, J.M. Casanovas, and F. Artigas Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas Neuropharmacology 36 1997 735 741 (Pubitemid 27273213)
2. Y. Ago, Y. Koyama, A. Baba, and T. Matsuda Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex Neuropharmacology 45 2003 1050 1056 (Pubitemid 37412250)
3. P.R. Albert, Q.Y. Zhou, H.H. Van Tol, J.R. Bunzow, and O. Civelli Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene J. Biol. Chem. 265 1990 5825 5832
4. J.T. Andreasen, E.O. Nielsen, and J.P. Redrobe Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim-test Psychopharmacology (Berl) 205 2009 517 528
5. J.T. Andreasen, and J.P. Redrobe Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests Behav. Brain. Res. 197 2009 150 156
6. M.B. Assie, L. Bardin, A.L. Auclair, E. Carilla-Durand, R. Depoortere, W. Koek, M.S. Kleven, F. Colpaert, B. Vacher, and A. Newman-Tancredi F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity Int. J. Neuropsychopharmacol. 13 2010 1285 1298
7. B. Bert, H. Fink, H. Hortnagl, R.W. Veh, B. Davies, F. Theuring, and H. Kusserow Mice over-expressing the 5-HT(1A) receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT Behav. Brain. Res. 167 2006 328 341 (Pubitemid 43099794)
8. B. Bert, H. Fink, J. Rothe, J. Walstab, and H. Bonisch Learning and memory in 5-HT(1A)-receptor mutant mice Behav. Brain. Res. 195 2008 78 85
9. B. Bert, J.P. Voigt, H. Kusserow, F. Theuring, A. Rex, and H. Fink Increasing the number of 5-HT(1A)-receptors in cortex and hippocampus does not induce mnemonic deficits in mice Pharmacol. Biochem. Behav. 92 2009 76 81
10. P. Blier, and C. de Montigny Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists J. Cardiovasc. Pharmacol. 15 Suppl. 7 1990 S42 S48
11. P. Blier, and N.M. Ward Is there a role for 5-HT1A agonists in the treatment of depression? Biol. Psychiatry. 53 2003 193 203 (Pubitemid 36135929)
12. M. Boldrini, M.D. Underwood, J.J. Mann, and V. Arango Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides J. Psychiatr. Res. 42 2008 433 442 (Pubitemid 351240919)
13. M. Bourin, J.P. Redrobe, and G.B. Baker Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test Psychopharmacology (Berl) 136 1998 226 234 (Pubitemid 28143171)
14. M. Carli, S. Tranchina, and R. Samanin 8-Hydroxy-2-(di-n-propylamino) tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task Eur. J. Neurosci. 211 1992 227 234
15. P. Celada, M. Puig, M. Amargos-Bosch, A. Adell, and F. Artigas The therapeutic role of 5-HT1A and 5-HT2A receptors in depression J. Psychiatry. Neurosci. 29 2004 252 265 (Pubitemid 39185866)
16. I.P. Chessell, P.T. Francis, M.N. Pangalos, R.C. Pearson, and D.M. Bowen Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurones Brain. Res. 632 1993 86 94
17. J.J. Crowley, J.A. Blendy, and I. Lucki Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test Psychopharmacology (Berl) 183 2005 257 264 (Pubitemid 41609278)
18. J.F. Cryan, M.E. Page, and I. Lucki Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim-test following chronic treatment Psychopharmacology (Berl) 182 2005 335 344 (Pubitemid 41464645)
19. J.F. Cryan, R.J. Valentino, and I. Lucki Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test Neurosci. Biobehav. Rev. 29 2005 547 569 (Pubitemid 40755456)
20. J.F. Cryan, and C. Mombereau In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice Mol. Psychiatry. 9 2004 326 357 (Pubitemid 38534696)
21. D.J. David, C.E. Renard, P. Jolliet, M. Hascoet, and M. Bourin Antidepressant-like effects in various mice strains in the forced swimming test Psychopharmacology (Berl) 166 2003 373 382 (Pubitemid 36503032)
22. K. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates 1997 Academic Press San Diego
23. M. Hajos, E. Hajos-Korcsok, and T. Sharp Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat Br. J. Pharmacol. 126 1999 1741 1750 (Pubitemid 29213091)
24. N. Jolimay, L. Franck, X. Langlois, M. Hamon, and M. Darmon Dominant role of the cytosolic C-terminal domain of the rat 5-HT1B receptor in axonal-apical targeting J. Neurosci. 20 2000 9111 9118 (Pubitemid 32042913)
25. H. Jovanovic, J. Lundberg, P. Karlsson, A. Cerin, T. Saijo, A. Varrone, C. Halldin, and A.L. Nordstrom Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET Neuroimage 39 2008 1408 1419
26. R. Keers, and K.J. Aitchison Gender differences in antidepressant drug response Int. review Psychiatry (Abingdon, England) 22 2010 485 500
27. A. Khan, A.E. Brodhead, K.A. Schwartz, R.L. Kolts, and W.A. Brown Sex differences in antidepressant response in recent antidepressant clinical trials J. Clin. Psychopharmacol. 25 2005 318 324 (Pubitemid 41060250)
28. H. Kusserow, B. Davies, H. Hortnagl, I. Voigt, T. Stroh, B. Bert, D.R. Deng, H. Fink, R.W. Veh, and F. Theuring Reduced anxiety-related behaviour in transgenic mice over-expressing serotonin 1A receptors Mol. Brain Res. 129 2004 104 116 (Pubitemid 39304254)
29. I.P. Lapin Only controls: effect of handling, sham injection, and intraperitoneal injection of saline on behavior of mice in an elevated plus-maze J. pharmacol. Toxicol. Methods 34 1995 73 77
30. G.M. Leggio, V. Micale, and F. Drago Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim-test (FST) Eur. Neuropsychopharmacol. 18 2008 271 277 (Pubitemid 351232176)
31. S. Lemonde, G. Turecki, D. Bakish, L. Du, P.D. Hrdina, C.D. Bown, A. Sequeira, N. Kushwaha, S.J. Morris, A. Basak, X.M. Ou, and P.R. Albert Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide J. Neurosci. 23 2003 8788 8799 (Pubitemid 37176660)
32. L. Llado-Pelfort, M.B. Assie, A. Newman-Tancredi, F. Artigas, and P. Celada Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors Br. J. Pharmacol. 160 2010 1929 1940
33. V. Maletic, M. Robinson, T. Oakes, S. Iyengar, S.G. Ball, and J. Russell Neurobiology of depression: an integrated view of key findings Int. J. Clin. Pract. 61 2007 2030 2040 (Pubitemid 350077413)
34. P.J. McGrath, J.W. Stewart, F.M. Quitkin, S. Wager, S.W. Jenkins, D.G. Archibald, J.C. Stringfellow, and D.S. Robinson Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement J. Clin. Psychopharmacol. 14 1994 347 352 (Pubitemid 24316934)
35. M.J. Millan, H. Canton, A. Gobert, F. Lejeune, J.M. Rivet, K. Bervoets, M. Brocco, P. Widdowson, T. Mennini, and V. Audinot Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists J. Pharmacol. Exp. Ther. 268 1994 337 352 (Pubitemid 24039107)
36. M.J. Millan, A. Newman-Tancredi, J.M. Rivet, M. Brocco, P. Lacroix, V. Audinot, L. Cistarelli, and A. Gobert S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity J. Pharmacol. Exp. Ther. 282 1997 132 147 (Pubitemid 27425536)
37. M.J. Millan, A. Dekeyne, M. Papp, C.D. La Rochelle, C. MacSweeny, J.L. Peglion, and M. Brocco S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine J. Pharmacol. Exp. Ther. 298 2001 581 591 (Pubitemid 32673408)
38. M.J. Millan, S. Veiga, S. Girardon, and M. Brocco Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes Psychopharmacology (Berl) 168 2003 397 409 (Pubitemid 37006349)
39. M.J. Millan Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application Pharmacol. Ther. 110 2006 135 370
40. I. Misane, C. Johansson, and S.O. Ogren Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat Br. J. Pharmacol. 125 1998 499 509 (Pubitemid 28451488)
41. A. Newman-Tancredi, C. Conte, C. Chaput, L. Verriele, and M.J. Millan Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry Neuropharmacology 36 1997 451 459 (Pubitemid 27272090)
42. 3H]-S 15535 Ann. N. Y. Acad. Sci. 861 1998 263 264 (Pubitemid 29047740)
43. A. Newman-Tancredi, S. Gavaudan, C. Conte, C. Chaput, M. Touzard, L. Verriele, V. Audinot, and M.J. Millan Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study Eur. J. Pharmacol. 355 1998 245 256 (Pubitemid 28404707)
44. D.M. Nielsen, G.J. Carey, and L.H. Gold Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice Eur. J. Pharmacol. 499 2004 135 146 (Pubitemid 39201220)
45. R.V. Parsey, M.A. Oquendo, N.R. Simpson, R.T. Ogden, R. Van Heertum, V. Arango, and J.J. Mann Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 Brain. Res. 954 2002 173 182 (Pubitemid 35284657)
46. A. Pazos, A. Probst, and J.M. Palacios Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors Neuroscience 21 1987 97 122 (Pubitemid 17076866)
47. M. Pompeiano, J.M. Palacios, and G. Mengod Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding J. Neurosci. 12 1992 440 453
48. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioural despair" in rats and mice: strain differences and the effects of imipramine Eur. J. Pharmacol. 51 1978 291 294 (Pubitemid 9208063)
49. Richardson-Jones, J.W., Craige, C.P., Guiard, B., Metzger, K.L., Dranovsky, A., David, D., Gardier, A.M., Beck, S.G., Hen, R., Leonardo, E., 2009. Dissociating the Roles of the 5-HT1A Auto- and Heteroreceptors in Depression and Anxiety: Insights from a Novel Genetic Mouse System., 40th Annual Meeting of the Society for Neuroscience, Chicago, p. 342.349/P348.
50. D.S. Robinson, K. Rickels, J. Feighner, L.F. Fabre Jr., R.E. Gammans, R.C. Shrotriya, D.R. Alms, J.J. Andary, and M.E. Messina Clinical effects of the 5-HT1A partial agonists in depression: a composite analysis of buspirone in the treatment of depression J. Clin. Psychopharmacol. 10 1990 67S 76S (Pubitemid 20212933)
51. A.E. Ryabinin, Y.M. Wang, and D.A. Finn Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice Pharmacol. Biochem. Behav. 63 1999 143 151 (Pubitemid 29206573)
52. C. Sanchez, and E. Meier Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology (Berl) 129 1997 197 205 (Pubitemid 27085389)
53. J. Savitz, I. Lucki, and W.C. Drevets 5-HT(1A) receptor function in major depressive disorder Prog. Neurobiol. 88 2009 17 31
54. L. Schiller, M. Jahkel, M. Kretzschmar, P. Brust, and J. Oehler Autoradiographic analyses of 5-HT1A and 5-HT2A receptors after social isolation in mice Brain. Res. 980 2003 169 178 (Pubitemid 36829435)
55. L. Schiller, M. Jahkel, and J. Oehler The influence of sex and social isolation housing on pre- and postsynaptic 5-HT1A receptors Brain. Res. 1103 2006 76 87 (Pubitemid 44080112)
56. J.S. Sprouse, and G.K. Aghajanian Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons Neuropharmacology 27 1988 707 715
57. S.M. Stahl, L. Kaiser, J. Roeschen, J.M. Keppel Hesselink, and J. Orazem Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants Int. J. Neuropsychopharmacol. 1 1998 11 18 (Pubitemid 128538360)
58. P. Stein, M. Savli, W. Wadsak, M. Mitterhauser, M. Fink, C. Spindelegger, L.K. Mien, U. Moser, R. Dudczak, K. Kletter, S. Kasper, and R. Lanzenberger The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635 Eur. J. Nucl. Med. Mol. Imaging. 35 2008 2159 2168
59. C.A. Stockmeier, L.A. Shapiro, G.E. Dilley, T.N. Kolli, L. Friedman, and G. Rajkowska Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity J. Neurosci. 18 1998 7394 7401 (Pubitemid 28425823)
60. E. Tanaka, and R.A. North Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex J. Neurophysiol. 69 1993 1749 1757 (Pubitemid 23162414)
61. K. Wedzony, A. Chocyk, W. Kolasiewicz, and M. Mackowiak Glutamatergic neurons of rat medial prefrontal cortex innervating the ventral tegmental area are positive for serotonin 5-HT1A receptor protein J. Physiol. Pharmacol. 58 2007 611 624
62. M.J. Weiser, C.D. Foradori, and R.J. Handa Estrogen receptor beta in the brain: from form to function Brain Res. Rev. 57 2008 309 320 (Pubitemid 351381766)
63. E.H. Wong, M.S. Sonders, S.G. Amara, P.M. Tinholt, M.F. Piercey, W.P. Hoffmann, D.K. Hyslop, S. Franklin, R.D. Porsolt, A. Bonsignori, N. Carfagna, and R.A. McArthur Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor Biol. Psychiatry. 47 2000 818 829 (Pubitemid 30254055)
64. S.J. Yang, S.Y. Kim, R. Stewart, J.M. Kim, I.S. Shin, S.W. Jung, M.S. Lee, S.H. Jeong, and T.Y. Jun Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: the CRESCEND study Psychiatry. Res. 2011